Welcome!

.NET Authors: Srinivasan Sundara Rajan, David Fletcher, Pat Romanski, Tad Anderson, Adine Deford

News Feed Item

Express Scripts Reports Fourth Quarter and Full Year Results

Provides Initial 2013 Earnings Guidance

ST. LOUIS, Feb. 18, 2013 /PRNewswire/ -- Express Scripts Holding Company (Nasdaq: ESRX) announced 2012 fourth quarter and full year net income attributable to Express Scripts shareholders from continuing operations of $515.9 million and $1,340.5 million, or $0.62 and $1.79 per diluted share, respectively. Adjusted earnings per share attributable to Express Scripts from continuing operations, as detailed in Table 4 were $1.05 and $3.74 per diluted share for the fourth quarter and full year, respectively.

"2012 was a monumental year for Express Scripts as we closed the acquisition of Medco and made significant progress integrating the two companies," stated George Paz, chairman and chief executive officer. "Our financial performance in 2012 was strong, and as we look to the future, we are well positioned to capitalize on the complementary strengths of the combined organization, which enhance our ability to improve health outcomes, lower health care costs and continue to deliver long-term growth."

Fourth Quarter 2012 Review (Results from continuing operations on an adjusted basis where indicated. See Tables 2 and 3)

All key metrics compared to 2011 were affected by the inclusion of Medco results beginning in the second quarter of 2012. Gross profit margin and EBITDA per adjusted claim increases over last year are mainly attributed to improved operating performance, increased generic utilization and realization of synergies.

  • Adjusted claims of 410.8 million, up 111%
  • Gross profit of $2.3 billion, up 160%
  • EBITDA of $1.6 billion, up 131%
  • EBITDA per adjusted claim of $4.01, up 10%
  • Cash flow from operations of $2.6 billion, compared to $0.5 billion in the fourth quarter of 2011

Full Year 2012 Review (Results from continuing operations on an adjusted basis where indicated. See Tables 2 and 3)

  • Adjusted claims of 1,395.7 million, up 86%
  • Gross profit of $7.5 billion, up 123%
  • EBITDA of $5.4 billion, up 103%
  • EBITDA per adjusted claim of $3.87, up 9%
  • Cash flow from operations of $4.8 billion, including merger-related costs, up from $2.2 billion in 2011

Due to the Federal Holiday on February 18, 2013, the Company expects to file its Annual Report on Form 10-K for the year ended December 31, 2012 with the Securities and Exchange Commission ("SEC") on Tuesday, February 19, 2013. However, in connection with this earnings release, the contents of the Form 10-K substantially in the form expected to be filed on Tuesday, February 19, 2013, are expected to be made available to the public on the "Investor Information" section of the Company's website at approximately 4:00 pm Eastern Time (3:00 p.m. Central Time) on Monday, February 18, 2013 at www.express-scripts.com/corporate. The Form 10-K, as filed with the SEC, will replace that document on the Company's website as soon as practicable following its filing with the SEC.

2013 Guidance

The Company expects to achieve adjusted earnings per diluted share from continuing operations for 2013 in the range of $4.20 to $4.30, or 12% to 15% growth over 2012. Adjusted earnings per share for 2013 exclude items as detailed in Table 6.

  • Total adjusted claims are expected to grow 5% to 7% from 1,395.7 million adjusted claims reported in 2012
  • Selling, general and administrative expense is expected to decline 8% to 10% from $2,365.9 million reported on an adjusted basis in 2012
  • EBITDA per adjusted claim is expected to grow 15% to 18% from $3.87 reported on an adjusted basis in 2012
  • Effective tax rate is expected to be approximately 39%
  • Diluted shares outstanding is expected to be in a range of 825 million to 835 million

About Express Scripts

Express Scripts (NASDAQ: ESRX) manages more than a billion prescriptions each year for tens of millions of patients. On behalf of our clients – employers, health plans, unions and government health programs – we make the use of prescription drugs safer and more affordable. Express Scripts uniquely combines three capabilities – behavioral sciences, clinical specialization and actionable data – to create Health Decision Science(SM), our innovative approach to help individuals make the best drug choices, pharmacy choices and health choices. Better decisions mean healthier outcomes.

Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery, specialty benefit management, benefit-design consultation, drug-utilization review, formulary management, and medical and drug data analysis services. The company also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.

For more information, visit Lab.Express-Scripts.com or follow @ExpressScripts on Twitter.

SAFE HARBOR STATEMENT

This press release contains forward-looking statements, including, but not limited to, statements related to the Company's plans, objectives, expectations (financial and otherwise) or intentions. Actual results may differ significantly from those projected or suggested in any forward-looking statements. Factors that may impact these forward-looking statements can be found in the Management's Discussion and Analysis of Financial Condition and Results of Operations in the Company's Form 10-K filed with the SEC on or about February 19, 2013. A copy of this form can be found at the Investor Relations section of Express Scripts' web site at http://www.express-scripts.com/corporate.

We do not undertake any obligation to release publicly any revisions to such forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.


EXPRESS SCRIPTS HOLDING COMPANY

Unaudited Consolidated Statement of Operations










Three Months Ended

December 31,


Year Ended

December 31,

(in millions, except per share data)

2012


2011


2012


2011









Revenues(*)

$ 27,410.7


$ 12,101.4


$ 93,858.1


$ 46,128.3

Cost of revenues(*)

25,107.8


11,256.9


86,527.9


42,918.4

   Gross profit

2,302.9


844.5


7,330.2


3,209.9

Selling, general and administrative

1,398.4


268.0


4,545.7


895.5

Operating income

904.5


576.5


2,784.5


2,314.4

Other (expense) income:








   Equity income from joint venture

5.5


-


14.9


-

   Interest income

4.6


4.6


10.6


12.4

   Interest expense and other

(157.4)


(115.4)


(619.0)


(299.7)


(147.3)


(110.8)


(593.5)


(287.3)

Income before income taxes

757.2


465.7


2,191.0


2,027.1

Provision for income taxes

234.4


173.7


833.3


748.6

Net income from continuing operations

522.8


292.0


1,357.7


1,278.5

Net loss from discontinued operations, net of tax

(11.8)


-


(27.6)


-

Net income

511.0


292.0


1,330.1


1,278.5

Less: Net income attributable to non-controlling interest

6.9


1.6


17.2


2.7

Net income attributable to Express Scripts

$ 504.1


$ 290.4


$ 1,312.9


$ 1,275.8









Weighted average number of common shares outstanding during the period:















   Basic

817.3


485.3


731.3


500.9

   Diluted

832.4


489.0


747.3


505.0









Basic earnings (loss) per share








   Continuing operations attributable to Express Scripts

$ 0.63


$ 0.60


$ 1.83


$ 2.55

   Discontinued operations attributable to Express Scripts

(0.01)


-


(0.04)


-

   Net earnings attributable to Express Scripts

0.62


0.60


1.80


2.55









Diluted earnings (loss) per share








   Continuing operations attributable to Express Scripts

$ 0.62


$ 0.59


$ 1.79


$ 2.53

   Discontinued operations attributable to Express Scripts

(0.01)


-


(0.04)


-

   Net earnings attributable to Express Scripts

0.61


0.59


1.76


2.53









Amounts attributable to Express Scripts shareholders:








   Income from continuing operations, net of tax

$ 515.9


$ 290.4


$ 1,340.5


$ 1,275.8

   Discontinued operations, net of tax

(11.8)


-


(27.6)


-

   Net income attributable to Express Scripts shareholders

$ 504.1


$ 290.4


$ 1,312.9


$ 1,275.8









(*) Includes retail pharmacy co-payments of $3,304.0 million and $1,412.6 million for the three months ended December 31, 2012 and 2011, respectively and $11,668.6 million and $5,786.6 million for the year ended December 31, 2012 and 2011, respectively.

EXPRESS SCRIPTS HOLDING COMPANY

Unaudited Consolidated Balance Sheet






December 31,


December 31,

(in millions)

2012


2011

Assets




Current assets:




Cash and cash equivalents

$ 2,793.9


$ 5,620.1

Restricted cash and investments

19.6


17.8

Receivables, net

5,480.6


1,915.7

Inventories

1,661.9


374.4

Deferred taxes

408.5


45.8

Prepaid expenses and other current assets

194.4


84.2

Current assets of discontinued operations

198.0


-

Total current assets

10,756.9


8,058.0

Property and equipment, net

1,634.3


416.2

Goodwill

29,359.8


5,485.7

Other intangible assets, net

16,037.9


1,620.9

Other assets

56.6


26.2

Noncurrent assets of discontinued operations

265.7


-

Total assets

$ 58,111.2


$ 15,607.0





Liabilities and stockholders' equity




Current liabilities:




Claims and rebates payable

$ 7,440.0


$ 2,874.1

Accounts payable

2,909.1


928.1

Accrued expenses

1,630.0


656.0

Current maturities of long-term debt

934.9


999.9

Current liabilities of discontinued operations

143.4


-

Total current liabilities

13,057.4


5,458.1

Long-term debt

14,980.1


7,076.4

Deferred taxes

5,948.8


546.5

Other liabilities

692.9


50.7

Noncurrent liabilities of discontinued operations

36.3


-

Total liabilities

34,715.5


13,131.7





Stockholders' equity:




Preferred stock, 15.0 shares authorized, $0.01 par value per share;




and no shares issued and outstanding

-


-

Common stock, 2,985.0 shares authorized, $0.01 par value per share;




shares issued: 818.1 and 690.7, respectively;




shares outstanding: 818.1 and 484.6, respectively

8.2


6.9

Additional paid-in capital

21,289.7


2,438.2

Accumulated other comprehensive income

18.9


17.0

Retained earnings

2,068.2


6,645.6


23,385.0


9,107.7





Common stock in treasury at cost, zero and 206.1 shares, respectively

-


(6,634.0)

Total Express Scripts stockholders' equity

23,385.0


2,473.7

Non-controlling interest

10.7


1.6

Total stockholders' equity

23,395.7


2,475.3

Total liabilities and stockholders' equity

$ 58,111.2


$ 15,607.0

EXPRESS SCRIPTS HOLDING COMPANY

Unaudited Consolidated Statement of Cash Flows


Year Ended

December 31,

(in millions)

2012


2011





Cash flows from operating activities:




Net income

$ 1,330.1


$ 1,278.5

Net loss from discontinued operations, net of tax

27.6


-

  Net income from continuing operations

1,357.7


1,278.5

Adjustments to reconcile net income to net cash provided by operating activities:




Depreciation and amortization

1,872.6


253.4

Deferred income taxes

(390.4)


137.8

Employee stock-based compensation expense

410.0


48.8

Bad debt expense

158.8


11.6

Deferred financing fees

43.6


81.0

Other, net

(118.5)


4.5

Changes in operating assets and liabilities, net of effects of acquisition:




Receivables

325.2


(206.1)

Inventories

(515.8)


8.0

Other current and noncurrent assets

303.2


119.2

Claims and rebates payable

82.8


207.5

Accounts payable

982.2


271.4

Other current and noncurrent liabilities

240.8


(22.5)

Net cash provided by operating activities - continuing operations

4,752.2


2,193.1

Net cash provided by operating activities - discontinued operations

29.4


-

Net cash flows provided by operating activities

4,781.6


2,193.1





Cash flows from investing activities:




Acquisitions, net of cash acquired

(10,326.4)


-

Purchases of property and equipment

(160.2)


(144.4)

Purchase of short-term investments

(2.8)


(25.0)

Proceeds from sale of short-term investments

4.6


45.0

Proceeds from sale of business

61.5


-

Other

(5.8)


0.5

Net cash used in investing activities - continuing operations

(10,429.1)


(123.9)

Acquisitions, cash acquired - discontinued operations

42.8


-

Net cash used in investing activities - discontinued operations

(5.4)


-

Net cash used in investing activities

(10,391.7)


(123.9)





Cash flows from financing activities:




Proceeds from long-term debt, net of discounts

7,458.9


5,580.3

Repayment of long-term debt

(3,868.5)


(0.1)

Repayment of revolving credit line, net

(1,000.0)


-

Proceeds from accounts receivable financing facility

600.0


-

Repayment of accounts receivable financing facility

(600.0)


-

Excess tax benefit relating to employee stock-based compensation

45.3


28.3

Net proceeds from employee stock plans

326.0


32.2

Deferred financing fees

(103.2)


(91.6)

Treasury stock acquired

-


(2,515.7)

Distributions paid to non-controlling interest

(8.1)


(1.1)

Other

-


(2.9)

Net cash provided by financing activities - continuing operations

2,850.4


3,029.4

Net cash used in financing activities - discontinued operations

(26.8)


-

Net cash provided by financing activities

2,823.6


3,029.4





Effect of foreign currency translation adjustment

2.0


(2.2)





Less: cash attributable to discontinued operations

(41.7)


-





Net (decrease) increase in cash and cash equivalents

(2,826.2)


5,096.4

Cash and cash equivalents at beginning of year

5,620.1


523.7

Cash and cash equivalents at end of year

$ 2,793.9


$ 5,620.1

Table 1

Express Scripts Holding Company Unaudited Consolidated Selected Information

(in millions)










Three Months Ended

December 31,


Year Ended

December 31,


2012


2011


2012


2011

Claims Volume








Continuing operations:








Network

299.2


156.4


1,020.7


600.4

Home delivery and specialty(1)

38.3


13.6


129.1


53.4

   Total claims

337.5


170.0


1,149.8


653.8









Total adjusted claims - continuing operations(2)

410.8


194.9


1,395.7


751.5









Discontinued operations:








Home delivery and specialty(1)

1.2


-


4.9


-









Total adjusted claims - discontinued operations(2)

3.6


-


14.7


-









Depreciation and Amortization (D&A):








Revenue amortization(3)

$ 28.5


$ 28.5


$ 114.0


$ 114.0

Cost of revenues depreciation

32.0


12.3


105.3


43.5

Selling, general and administrative depreciation

58.4


14.9


178.9


55.2

Selling, general and administrative amortization

483.1


10.2


1,474.4


40.7

   Total D&A - continuing operations

$ 602.0


$ 65.9


$ 1,872.6


$ 253.4









Generic Fill Rate








Network

80.6%


75.8%


79.4%


75.3%

Home delivery

73.7%


64.7%


71.5%


63.0%

Overall

79.8%


74.8%


78.5%


74.2%









Note: See Appendix for Footnotes and Additional Notes.

    

Table 2

Calculation of Express Scripts Holding Company Adjusted Gross Profit and SG&A - Continuing Operations

(in millions)










Three Months Ended

December 31,


Year Ended

December 31,


2012


2011


2012


2011

Gross profit, as reported

$ 2,302.9


$ 844.5


$ 7,330.2


$ 3,209.9

Amortization of legacy Express Scripts intangible assets (3)

28.5


28.5


114.0


114.0

Non-recurring transaction and integration costs (4)

16.0


-


49.7


-

Accrual related to client contractual dispute (5)

-


30.0


-


30.0

Adjusted gross profit

$ 2,347.4


$ 903.0


$ 7,493.9


$ 3,353.9









Selling, general and administrative, as reported

$ 1,398.4


$ 268.0


$ 4,545.7


$ 895.5

Amortization of legacy Express Scripts intangible assets (3)

10.2


10.2


40.7


40.7

Amortization of Medco-related intangible assets (6)

472.9


-


1,433.7


-

Non-recurring transaction and integration costs (4)

130.8


42.2


705.4


62.5

Adjusted selling, general and administrative

$ 784.5


$ 215.6


$ 2,365.9


$ 792.3









Note: See Appendix for Footnotes and Additional Notes.

    



The Company is providing adjusted gross profit and adjusted selling, general and administrative expenses, in each case, excluding the impact of non-recurring charges and amortization of intangible assets (both of which are non-GAAP financial measures) in order to compare the underlying financial performance to prior periods.

    

Table 3

Express Scripts Holding Company EBITDA Reconciliation

(in millions, except per claim data)

The following is a reconciliation of net income from continuing operations attributable to Express Scripts to EBITDA from continuing operations attributable to Express Scripts. The Company believes net income is the most directly comparable measure calculated under U.S. GAAP.


Three Months Ended

December 31,


Year Ended

December 31,


2012


2011


2012


2011

Net income from continuing operations, attributable to Express Scripts, as reported

$ 515.9


$ 290.4


$ 1,340.5


$ 1,275.8

  Provision for income taxes

234.4


173.7


833.3


748.6

  Depreciation and amortization

602.0


65.9


1,872.6


253.4

  Interest expense, net

152.8


110.8


608.4


287.3

  Equity income from joint venture

(5.5)


-


(14.9)


-

EBITDA from continuing operations, attributable to Express Scripts, as reported

1,499.6


640.8


4,639.9


2,565.1

Non-recurring transaction and integration costs (4)

146.8


42.2


755.1


62.5

Accrual related to client contractual dispute (5)

-


30.0


-


30.0

Adjusted EBITDA from continuing operations, attributable to Express Scripts

$ 1,646.4


$ 713.0


$ 5,395.0


$ 2,657.6









Total adjusted claims - continuing operations

410.8


194.9


1,395.7


751.5









Adjusted EBITDA per adjusted claim

$ 4.01


$ 3.66


$ 3.87


$ 3.54









Note: See Appendix for Footnotes and Additional Notes.





    



The Company is providing adjusted EBITDA excluding the impact of non-recurring charges in order to compare the underlying financial performance to prior periods.


EBITDA is earnings before other income (expense), interest, taxes, depreciation and amortization, or alternatively calculated as operating income plus depreciation and amortization. EBITDA is presented because it is a widely accepted indicator of a company's ability to service indebtedness and is frequently used to evaluate a company's performance. EBITDA, however, should not be considered as an alternative to net income, as a measure of operating performance, as an alternative to cash flow, as a measure of liquidity or as a substitute for any other measure computed in accordance with accounting principles generally accepted in the United States. In addition, our definition and calculation of EBITDA may not be comparable to that used by other companies.


Adjusted EBITDA per adjusted claim is a supplemental measurement used by analysts and investors to help evaluate overall operating performance. We have calculated adjusted EBITDA excluding certain charges recorded each year, as these charges are not considered an indicator of ongoing company performance. Adjusted EBITDA per adjusted claim is calculated by dividing adjusted EBITDA by the adjusted claim volume for the period. This measure is used as an indicator of EBITDA performance on a per-unit basis. Adjusted EBITDA, and as a result, adjusted EBITDA per adjusted claim, are affected by the changes in claim volumes between retail and mail-order, the relative representation of brand-name, generic and specialty pharmacy drugs, as well as the level of efficiency in the business.

    

Table 4

Calculation of Express Scripts Holding Company Adjusted EPS










Three Months Ended

December 31,


Year Ended

December 31,


2012


2011


2012


2011




(per diluted share)



EPS from continuing operations attributable to Express Scripts, as reported

$ 0.62


$ 0.59


$ 1.79


$ 2.53









Non-recurring/transaction-related items:








Transaction and integration costs (4)

0.11


0.06


0.61


0.08

Medco acquisition pre-close financing costs (7)

-


0.08


0.07


0.13

Discrete tax items (8)

(0.06)


-


(0.01)


-

Accrual related to client contractual dispute (5)

-


0.04


-


0.04









Amortization of:








Legacy Express Scripts intangible assets(3)

0.03


0.05


0.12


0.19

Medco-related intangible assets(6)

0.35


-


1.16


-









EPS from continuing operations, adjusted

$ 1.05


$ 0.82


$ 3.74


$ 2.97









EPS from discontinued operations attributable to Express Scripts, as reported

$ (0.01)


$ -


$ (0.04)


$ -









Non-recurring/transaction-related items:








Transaction and integration costs (9)

-


-


0.01


-









Amortization of:








Medco-related intangible assets(9)

-


-


0.02


-









EPS from discontinued operations, adjusted

$ (0.01)


$ -


$ (0.01)


$ -









Total EPS attributable to Express Scripts, adjusted

$ 1.04


$ 0.82


$ 3.73


$ 2.97









Note: See Appendix for Footnotes and Additional Notes.









The Company is providing EPS and EPS excluding the impact of non-recurring / transaction-related items and amortization of intangible assets (which is a non-GAAP financial measure) in order to compare the underlying financial performance to prior periods.










Table 5

Calculation of Express Scripts Holding Company Adjusted Effective Income Tax Rate

(in millions)


Year Ended

December 31, 2012




Pre-Tax


Provision for Income Taxes


Adjusted Effective Income Tax Rate



Income from continuing operations, as reported

2,191.0


833.3





Income from discontinued operations, as reported

(15.4)


12.2






2,175.6


845.5





Non-controlling interest

(17.2)


-





Total operations attributable to Express Scripts

2,158.4


845.5





Discrete tax items(8)

-


8.2





Total operations attributable to Express Scripts

2,158.4


853.7


39.6%











Note: See Appendix for Footnotes and Additional Notes.









The Company is providing adjusted effective income tax rate excluding the impact of discrete tax items (which is a non-GAAP financial measure) in order to compare the underlying financial performance to prior periods.

         


Table 6

2013 Guidance Information


Estimated

Year Ended

December 31, 2013


(per diluted share)





Adjusted EPS from continuing operations guidance

$ 4.20

to

$ 4.30





GAAP items not included in guidance:








Amortization of legacy Express Scripts intangible assets

$0.11



Amortization of Medco-related intangible assets (10)

$1.38





Transaction, integration and other non-recurring costs(11)

To be determined





Note: See Appendix for Footnotes and Additional Notes.


The full-year impact of Medco-related transaction and integration costs have yet to be determined. Accordingly, the Company is unable to include these charges in the list of GAAP items not included in guidance for 2013 revised adjusted EPS from continuing operations or to provide a reconciliation to the corresponding GAAP measure.

Appendix

Footnotes


(1) Includes home delivery, specialty and other including: (a) drugs distributed through patient assistance programs (b) drugs we distribute to other PBMs' clients under limited distribution contracts with pharmaceutical manufacturers and (c) FreedomFP claims.


(2) Total adjusted claims reflect home delivery claims multiplied by 3, as home delivery claims typically cover a time period 3 times longer than retail claims.


(3) Amortization of legacy Express Scripts intangible assets include amounts in both revenues and selling, general and administrative expense. Revenue amortization is related to the customer contract with WellPoint which consummated upon closing of the NextRx acquisition in 2009. Under U.S. GAAP standards, amortization of intangibles that arise in connection with consideration given to a customer by a vendor is characterized as a reduction of revenues. Intangible amortization of $28.5 million ($17.1 million and $17.9 million net of tax in 2012 and 2011, respectively) is included as a reduction to revenue for the three months ended December 31, 2012 and 2011. Intangible amortization of $114.0 million ($68.8 million and $71.9 million net of tax in 2012 and 2011, respectively) is included as a reduction to revenue for the year ended December 31, 2012 and 2011.

 

In addition, intangible amortization of $10.2 million ($6.1 million and $6.4 million net of tax in 2012 and 2011, respectively) is included in selling, general and administrative expense in the three months ended December 31, 2012 and 2011. Intangible amortization of $40.7 million ($24.5 million and $25.7 million net of tax in 2012 and 2011, respectively) is included in selling, general and administrative expense in the year ended December 31, 2012 and 2011.


(4) Non-recurring transaction and integration costs include those directly related to the acquisition of Medco Health Solutions, Inc. ("Medco").

 

Costs of $16.0 million ($10.4 million net of tax) and $49.7 million ($30.0 million net of tax) for the three months and year ended December 31, 2012, respectively, primarily composed of integration-related activities, are included in cost of revenues.

 

Costs of $131.3 million ($85.0 million net of tax) and $42.2 million ($26.4 million net of tax) primarily composed of severance costs, including stock compensation, are included in selling, general and administrative expense in the three months ended December 31, 2012 and 2011, respectively. Costs of $697.2 million ($420.7 million net of tax) and $62.5 million ($39.4 million net of tax) are included in selling, general and administrative expense in the years ended December 31, 2012 and 2011, respectively.

 

The Company recorded a net benefit of $0.5 million ($0.4 million net of tax) and net charges of $8.2 million ($4.9 million net of tax) within selling, general and administrative expenses for the three months and year ended December 31, 2012, respectively, in conjunction with the strategic decision to exit various businesses.


(5) In December 2011, the Company recorded an accrual of $30 million ($18.9 million net of tax) as an offset to revenues for the year ended December 31, 2011 related to a client contractual dispute.


(6) Amortization of intangible assets related to the acquisition of Medco of $472.9 million ($289.6 million net of tax) and $1,433.7 million ($865.2 million net of tax) for the three months and year ended December 31, 2012, respectively is included in selling, general and administrative expense.


(7) Financing costs include fees related to the amortization of remaining bridge loan fees, commitment fees related to the new credit agreement and interest and fees on the senior notes secured in conjunction with the acquisition of Medco. Costs of $63.1 million ($39.5 million net of tax) is included in interest expense in the three months ended December 31, 2011. Costs of $85.2 million ($52.3 million net of tax) and $105.0 million ($66.2 million net of tax) is included in interest expense for the years ended December 31, 2012 and 2011, respectively.


(8) Provision for income taxes includes discrete tax benefits of $51.7 million and $8.2 million for the quarter and year ended December 31, 2012, respectively. These items primarily relate to adjustments to prior year income tax return filings partially offset by a reversal of the deferred tax asset previously established for transaction-related costs that became nondeductible upon the consummation of the Merger.


(9) Net income from discontinued operations, net of tax includes $8.1 million ($5.0 million net of tax) and $25.1 million ($15.2 million net of tax) of amortization of intangible assets related to the acquisition of Medco for the three months and year ended December 31, 2012, respectively.

 

In addition, net income from discontinued operations, net of tax for the three months and year ended December 31, 2012, respectively includes a benefit of $3.7 million ($2.3 million net of tax) and charges of $7.8 million ($4.8 million net of charges) in conjunction with the strategic decision to exit various businesses.


(10) Adjusted EPS will exclude amortization of intangible assets. The current estimate of full year amortization based on the preliminary purchase price allocation for the Medco transaction. The preliminary purchase price allocation may be subject to further refinement and may result in significant changes.


(11) Adjusted EPS will exclude Medco-related transaction, integration and other non-recurring costs, including premium on early retirement of debt. The full-year impact of these costs have yet to be determined.

Appendix

Additional Notes


The Company now recognizes net income attributable to non-controlling interest which represents the share of net income allocated to members in consolidated affiliates. This share of net income was previously included within selling, general and administrative costs on the consolidated statement of operations. This classification impacted all quarters in 2012 and the third and fourth quarters of 2011 and did not impact net income attributable to Express Scripts shareholders.

 

During the fourth quarter of 2012, the Company determined that portions of the business within the Other Business Operations segment were not core to future operations and committed to a plan to dispose of these businesses. Consequently, results for the year ended December 31, 2012 have been adjusted for the discontinued operations of these businesses. This adjustment for discontinued operations impacts the second, third and fourth quarters of 2012.


Consult the Investor Information section of the Express Scripts website for the 2012 Express Scripts Recast worksheet, a document that recasts historical information reflecting these changes as www.express-scripts.com/corporate

SOURCE Express Scripts Holding Company

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

@ThingsExpo Stories
“In the past year we've seen a lot of stabilization of WebRTC. You can now use it in production with a far greater degree of certainty. A lot of the real developments in the past year have been in things like the data channel, which will enable a whole new type of application," explained Peter Dunkley, Technical Director at Acision, in this SYS-CON.tv interview at @ThingsExpo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events announced today that Windstream, a leading provider of advanced network and cloud communications, has been named “Silver Sponsor” of SYS-CON's 16th International Cloud Expo®, which will take place on June 9–11, 2015, at the Javits Center in New York, NY. Windstream (Nasdaq: WIN), a FORTUNE 500 and S&P 500 company, is a leading provider of advanced network communications, including cloud computing and managed services, to businesses nationwide. The company also offers broadband, phone and digital TV services to consumers primarily in rural areas.
The Internet of Things is not new. Historically, smart businesses have used its basic concept of leveraging data to drive better decision making and have capitalized on those insights to realize additional revenue opportunities. So, what has changed to make the Internet of Things one of the hottest topics in tech? In his session at @ThingsExpo, Chris Gray, Director, Embedded and Internet of Things, discussed the underlying factors that are driving the economics of intelligent systems. Discover how hardware commoditization, the ubiquitous nature of connectivity, and the emergence of Big Data a...

ARMONK, N.Y., Nov. 20, 2014 /PRNewswire/ --  IBM (NYSE: IBM) today announced that it is bringing a greater level of control, security and flexibility to cloud-based application development and delivery with a single-tenant version of Bluemix, IBM's platform-as-a-service. The new platform enables developers to build ap...

SYS-CON Events announced today that IDenticard will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. IDenticard™ is the security division of Brady Corp (NYSE: BRC), a $1.5 billion manufacturer of identification products. We have small-company values with the strength and stability of a major corporation. IDenticard offers local sales, support and service to our customers across the United States and Canada. Our partner network encompasses some 300 of the world's leading systems integrators and security s...
DevOps Summit 2015 New York, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that it is now accepting Keynote Proposals. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long development cycles that produce software that is obsolete at launch. DevOps may be disruptive, but it is essential.
The major cloud platforms defy a simple, side-by-side analysis. Each of the major IaaS public-cloud platforms offers their own unique strengths and functionality. Options for on-site private cloud are diverse as well, and must be designed and deployed while taking existing legacy architecture and infrastructure into account. Then the reality is that most enterprises are embarking on a hybrid cloud strategy and programs. In this Power Panel at 15th Cloud Expo (http://www.CloudComputingExpo.com), moderated by Ashar Baig, Research Director, Cloud, at Gigaom Research, Nate Gordon, Director of T...
"BSQUARE is in the business of selling software solutions for smart connected devices. It's obvious that IoT has moved from being a technology to being a fundamental part of business, and in the last 18 months people have said let's figure out how to do it and let's put some focus on it, " explained Dave Wagstaff, VP & Chief Architect, at BSQUARE Corporation, in this SYS-CON.tv interview at @ThingsExpo, held Nov 4-6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
"People are a lot more knowledgeable about APIs now. There are two types of people who work with APIs - IT people who want to use APIs for something internal and the product managers who want to do something outside APIs for people to connect to them," explained Roberto Medrano, Executive Vice President at SOA Software, in this SYS-CON.tv interview at Cloud Expo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
Nigeria has the largest economy in Africa, at more than US$500 billion, and ranks 23rd in the world. A recent re-evaluation of Nigeria's true economic size doubled the previous estimate, and brought it well ahead of South Africa, which is a member (unlike Nigeria) of the G20 club for political as well as economic reasons. Nigeria's economy can be said to be quite diverse from one point of view, but heavily dependent on oil and gas at the same time. Oil and natural gas account for about 15% of Nigera's overall economy, but traditionally represent more than 90% of the country's exports and as...
The Internet of Things is a misnomer. That implies that everything is on the Internet, and that simply should not be - especially for things that are blurring the line between medical devices that stimulate like a pacemaker and quantified self-sensors like a pedometer or pulse tracker. The mesh of things that we manage must be segmented into zones of trust for sensing data, transmitting data, receiving command and control administrative changes, and peer-to-peer mesh messaging. In his session at @ThingsExpo, Ryan Bagnulo, Solution Architect / Software Engineer at SOA Software, focused on desi...
"At our booth we are showing how to provide trust in the Internet of Things. Trust is where everything starts to become secure and trustworthy. Now with the scaling of the Internet of Things it becomes an interesting question – I've heard numbers from 200 billion devices next year up to a trillion in the next 10 to 15 years," explained Johannes Lintzen, Vice President of Sales at Utimaco, in this SYS-CON.tv interview at @ThingsExpo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
"For over 25 years we have been working with a lot of enterprise customers and we have seen how companies create applications. And now that we have moved to cloud computing, mobile, social and the Internet of Things, we see that the market needs a new way of creating applications," stated Jesse Shiah, CEO, President and Co-Founder of AgilePoint Inc., in this SYS-CON.tv interview at 15th Cloud Expo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events announced today that Gridstore™, the leader in hyper-converged infrastructure purpose-built to optimize Microsoft workloads, will exhibit at SYS-CON's 16th International Cloud Expo®, which will take place on June 9-11, 2015, at the Javits Center in New York City, NY. Gridstore™ is the leader in hyper-converged infrastructure purpose-built for Microsoft workloads and designed to accelerate applications in virtualized environments. Gridstore’s hyper-converged infrastructure is the industry’s first all flash version of HyperConverged Appliances that include both compute and storag...
Today’s enterprise is being driven by disruptive competitive and human capital requirements to provide enterprise application access through not only desktops, but also mobile devices. To retrofit existing programs across all these devices using traditional programming methods is very costly and time consuming – often prohibitively so. In his session at @ThingsExpo, Jesse Shiah, CEO, President, and Co-Founder of AgilePoint Inc., discussed how you can create applications that run on all mobile devices as well as laptops and desktops using a visual drag-and-drop application – and eForms-buildi...
We certainly live in interesting technological times. And no more interesting than the current competing IoT standards for connectivity. Various standards bodies, approaches, and ecosystems are vying for mindshare and positioning for a competitive edge. It is clear that when the dust settles, we will have new protocols, evolved protocols, that will change the way we interact with devices and infrastructure. We will also have evolved web protocols, like HTTP/2, that will be changing the very core of our infrastructures. At the same time, we have old approaches made new again like micro-services...
Code Halos - aka "digital fingerprints" - are the key organizing principle to understand a) how dumb things become smart and b) how to monetize this dynamic. In his session at @ThingsExpo, Robert Brown, AVP, Center for the Future of Work at Cognizant Technology Solutions, outlined research, analysis and recommendations from his recently published book on this phenomena on the way leading edge organizations like GE and Disney are unlocking the Internet of Things opportunity and what steps your organization should be taking to position itself for the next platform of digital competition.
The 3rd International Internet of @ThingsExpo, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that its Call for Papers is now open. The Internet of Things (IoT) is the biggest idea since the creation of the Worldwide Web more than 20 years ago.
As the Internet of Things unfolds, mobile and wearable devices are blurring the line between physical and digital, integrating ever more closely with our interests, our routines, our daily lives. Contextual computing and smart, sensor-equipped spaces bring the potential to walk through a world that recognizes us and responds accordingly. We become continuous transmitters and receivers of data. In his session at @ThingsExpo, Andrew Bolwell, Director of Innovation for HP's Printing and Personal Systems Group, discussed how key attributes of mobile technology – touch input, sensors, social, and ...
In their session at @ThingsExpo, Shyam Varan Nath, Principal Architect at GE, and Ibrahim Gokcen, who leads GE's advanced IoT analytics, focused on the Internet of Things / Industrial Internet and how to make it operational for business end-users. Learn about the challenges posed by machine and sensor data and how to marry it with enterprise data. They also discussed the tips and tricks to provide the Industrial Internet as an end-user consumable service using Big Data Analytics and Industrial Cloud.